Moderna seeks approval of COVID-19 booster for all adults By Tom Howell Jr. - The Washington Times Shares
‘Breakthrough’ infections surge, disrupting workforce and complicating COVID-19 response By Tom Howell Jr. - The Washington Times Shares
Germany recommends Pfizer over Moderna for those younger than 30 By Tom Howell Jr. - The Washington Times Shares
Science says coronavirus vaccines, over time, barely effective By Cheryl K. Chumley - The Washington Times Shares
Elevated risk of clots in J&J vaccine recipients, says Mayo Clinic study By Tom Howell Jr. - The Washington Times Shares
Jen Psaki’s COVID-19 underscores fallacies of vaccine mandates By Cheryl K. Chumley - The Washington Times Shares
Moderna agrees to provide 110M doses of COVID-19 vaccine to Africa By Tom Howell Jr. - The Washington Times Shares
U.S. surgeon general: Fine for Pfizer, Moderna recipients to stick to the same brand for booster By Tom Howell Jr. - The Washington Times Shares
Pfizer vaccine booster highly effective in late-stage trial By Shen Wu Tan - The Washington Times Shares
CDC panel advances plan for mix-and-match booster vaccines for COVID-19 By Tom Howell Jr. - The Washington Times Shares
FDA official: Booster announcements coming Wednesday By Matthew Perrone and Lauran Neergaard - Associated Press Shares
FDA approves J&J and Moderna boosters, mixing vaccines By Tom Howell Jr. - The Washington Times Shares
FDA eyeing plan to allow mix-and-match of COVID-19 vaccine booster, report says By Tom Howell Jr. - The Washington Times Shares
FDA panel takes up tough questions on J&J COVID-19 boosters By Matthew Perrone and Lauran Neergaard - Associated Press Shares
Next on FDA’s agenda: Booster shots of Moderna, J&J vaccines By Lauran Neergaard and Matthew Perrone - Associated Press Shares
Pfizer downplays COVID-19 vaccine’s ties to fetal tissue from abortions: Project Veritas By Valerie Richardson - The Washington Times Shares